Design, Synthesis, and Applications of 3-Aza-6,8-Dioxabicyclo[3.2.1]Octane-Based Scaffolds for Peptidomimetic Chemistry

Abstract

During the last three decades numerous peptides have been introduced in the treatment of several diseases, though, due to their low bioavailability, non-peptide compounds have been preferred for the generation of new therapeutic agents presenting a peptide as lead candidate. Thus, much effort has been devoted towards the development of isosteres capable to mimic either backbone or side chain structures, in order to improve biological stability and potency, and to reduce the complexity of the lead peptide. Such process has taken advantage of the synthesis of compounds using combinatorial library methodologies, which have achieved a major role in drug discovery, and recently, diversity-oriented synthesis has gained interest from many organic and medicinal chemists. Our group has focused on the development of a new class of bicyclic molecular scaffolds named BTAa (Bicycles from Tartaric acid and Amino acids), having a 3-aza-6,8-dioxa-bicyclo[3.2.1]octane as core structure, and amino acid side chain functionalities on ­stereodefined positions. These molecules are good templates for peptidomimetic design, and examples varying substituents, ­stereochemistry and ring-size have been reported using different synthetic strategies. Moreover, scaffolds derived from amino ketones and sugar derivatives (BTKa) have been synthesised on solid phase, thus exploring new methodologies for the generation of focused libraries of peptidomimetics. These compounds have been applied as dipeptide isosteres by the introduction in a cyclic oligopeptide chymotripsin inhibitor, and it has been demonstrated that BTAa scaffolds having the carboxylic group in 7-endo position can be considered as mimetics of β-turns in cyclic and linear peptides. New synthetic methodologies for proline-like bicyclic scaffolds have been developed for the production of different species of reverse-turn inducers, and BTAa scaffolds as γ/δ-amino acids have been used as monomers for the synthesis of oligomeric structures.

• 1 Introduction

• 2 3-Aza-6,8-dioxabicyclo[3.2.1]octane-Based Scaffolds

• 2.1 Formal COOH Shift

• 2.2 BTKa and 7-endo-BTKa

• 2.3 [4.2.1]- and [5.2.1]-Sized Scaffolds

• 2.4 Towards Polycyclic Scaffolds

• 2.5 Chemical Stability

• 2.6 Structural Features

• 3 Bicyclic Scaffolds for Combinatorial Chemistry

• 3.1 Ketone on Resin

• 3.2 Sugar Moiety on Resin

• 3.3 Amine on Resin

• 3.4 Parallel Synthesis of Amides

• 4 Bicyclic Scaffolds in Foldamer Design

• 5 Bicyclic Scaffolds as Reverse-Turn Inducers

• 5.1 BTAa as Reverse-Turn Mimetics in Cyclic Peptides

• 5.2 BTAa as Reverse-Turn Mimetics in Linear Model Peptides

• 5.3 Model Peptides for BGS Scaffolds as Proline Mimetics

• 6 Concluding Remarks

peptidomimetics - solid-phase synthesis - peptides - conformational analysis - combinatorial chemistry

References and Notes

1 Giannis A. Kolter T. Angew. Chem., Int. Ed. Engl.  1993,  32:  1244 

2 Gante J. Angew. Chem., Int. Ed. Engl.  1994,  33:  1699 

3 Adessi C. Soto C. Curr. Med. Chem.  2002,  9:  963 

4 Liskamp RMJ. Recl. Trav. Chim. Pays-Bas  1994,  113:  1 

5 Olson GL. Bolin DR. Bonner MP. Bös M. Cook CM. Fry DC. Graves BJ. Hatada M. Hill DE. Kahn M. Madison VS. Rusiecki VK. Sarabu R. Sepinwall J. Vincent GP. Voss ME. J. Med. Chem.  1993,  36:  3039 

6 Ripka AS. Rich DH. Curr. Opin. Chem. Biol.  1998,  2:  441 

7 Hirschmann R. Nicolau KC. Pietranico S. Leahy EM. Salvino J. Arison B. Cichy MA. Spoors PG. Shakespeare WC. Sprengeler PA. Hamley P. Smith AB. Reisine T. Raynor K. Maechler L. Donaldson C. Vale W. Freidinger RM. Cascieri MR. Strader CD. J. Am. Chem. Soc.  1993,  115:  12550 

8 Hirschmann R. Sprengeler PA. Kawasaki T. Leahy JW. Shakespeare WC. Smith AB. J. Am. Chem. Soc.  1992,  114:  9699 

9 Lam KS. Lebl M. Krchňák V. Chem. Rev.  1997,  97:  411 

10 Dolle RE. J. Comb. Chem.  2001,  3:  477 

11 Dolle RE. J. Comb. Chem.  2002,  4:  369 

12 Dolle RE. J. Comb. Chem.  2003,  5:  693 

13 Dolle RE. J. Comb. Chem.  2004,  6:  623 

14 Thompson LA. Ellman JA. Chem. Rev.  1996,  96:  555 

15 Nefzi A. Ostresh JM. Houghten RA. Chem. Rev.  1997,  97:  449 

16 Golebiowski A. Klopfenstein SR. Shao X. Chen JJ. Colson A.-O. Grieb AL. Russell AF. Org. Lett.  2000,  2:  2615 

17 Creighton CJ. Zapf CW. Bu JH. Goodman M. Org. Lett.  1999,  1:  1407 

18 Kim HO. Nakanishi H. Lee MS. Kahn M. Org. Lett.  2000,  2:  301 

19 Eguchi M. Lee MS. Nakanishi H. Stasiak M. Lovell S. Kahn M. J. Am. Chem. Soc.  1999,  121:  12204 

20 Guarna A. Guidi A. Machetti F. Menchi G. Occhiato EG. Scarpi D. Sisi S. Trabocchi A. J. Org. Chem.  1999,  64:  7347 

21 Cini N. Machetti F. Menchi G. Occhiato EG. Guarna A. Eur. J. Org. Chem.  2002,  873 

22 Trabocchi A. Menchi G. Rolla M. Machetti F. Bucelli I. Guarna A. Tetrahedron  2003,  59:  5251 

23 Trabocchi A. Cini N. Menchi G. Guarna A. Tetrahedron Lett.  2003,  44:  3489 

24 Guarna A. Bucelli I. Machetti F. Menchi G. Occhiato EG. Scarpi D. Trabocchi A. Tetrahedron  2002,  58:  9865 

25 Guarna A, Menchi G, Machetti F, Occhiato EG, and Scarpi D. inventors; WO  01/64686.  ; Chem. Abstr. 2001, 135, 211044

26 Trabocchi A. Mancini F. Menchi G. Guarna A. Mol. Diversity  2003,  6:  245 

27 Scarpi D. Stranges D. Cecchi L. Guarna A. Tetrahedron  2004,  60:  2583 

28 Danieli E. Trabocchi A. Menchi G. Guarna A. Eur. J. Org. Chem.  2005,  4372 

29 Trabocchi A. Rolla M. Menchi G. Guarna A. Tetrahedron Lett.  2005,  46:  7813 

30

TBDMS-protected 3-amino-1,2-propanediol was obtained in high purity and yield after a two-step process involving reaction of benzylamine with TBDMS-protected glycidol in the presence of LiNTf₂, and subsequent hydrogenation of the benzylic group.

31 The use of anhydride followed by SOCl₂ treatment was reported for the preparation of BTG. See: Dienes Z. Vogel P. J. Org. Chem.  1996,  61:  6958 

32 Reymond J.-L. Vogel P. J. Chem. Soc., Chem. Commun.  1990,  1070 

33 Reymond J.-L. Vogel P. Tetrahedron: Asymmetry  1990,  1:  729 

34

Crystallographic data (excluding structure factors) for the structure 110 in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 286087. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: [phone] or e-mail: [e-mail]].

35 Hanessian S. Xie F. Tetrahedron Lett.  1998,  39:  733 

36 Christensen T. Acta Chem. Scand., Ser. B  1979,  33:  763 

37 The Bromophenol Blue test is not specific, as it reveals the presence of primary to quaternary amines. See: Krchnák V. Vágner J. Safár P. Lebl M. Collect. Czech. Chem. Commun.  1988,  53:  2542 

38 Furman B. Thürmer R. Kaluża Z. Lysek R. Voelter W. Chmielewski M. Angew. Chem. Int. Ed.  1999,  38:  1121 

39 Purandare AV. Poss MA. Tetrahedron Lett.  1998,  39:  935 

40 Caputo R. Cassano E. Longobardo L. Palumbo G. Tetrahedron  1995,  51:  12337 

41 Yan LZ. Mayer JP. J. Org. Chem.  2003,  68:  1161 

42 Abdel-Magid AF. Carson KG. Harris BD. Maryanoff CA. Shah RD. J. Org. Chem.  1996,  61:  3849 

43 This compound was obtained by oxidative cleavage of d-1,2:5,6-di-O-isopropylidene-mannitol with NaIO₄ as reported. See: Earle MJ. Abdur-Rashid A. Priestley ND. J. Org. Chem.  1996,  61:  5697 

44 Machetti F. Bucelli I. Indiani G. Guarna A. C. R. Chimie  2003,  6:  631 

45 Gellman SH. Acc. Chem. Res.  1998,  31:  173 

46 Hill DJ. Mio MJ. Prince RB. Hughes TS. Moore JS. Chem. Rev.  2001,  101:  3893 

47 Machetti F. Ferrali A. Menchi G. Occhiato EG. Guarna A. Org. Lett.  2000,  2:  3987 

48 Chou PY. Fasman GD. J. Mol. Biol.  1977,  115:  135 

49 Rose GD. Gierasch LM. Smith JA. Adv. Protein Chem.  1985,  37:  1 

50 Stanfield RL. Fieser TM. Lerner RA. Wilson IA. Science  1990,  248:  712 

51 Müller G. Hessler G. Decornez HY. Angew. Chem. Int. Ed.  2000,  39:  894 

52 Richardson JS. Adv. Protein Chem.  1981,  34:  167 

53 Müller G. Angew. Chem., Int. Ed. Engl.  1996,  35:  2767 

54 Belvisi L. Gennari C. Mielgo A. Potenza D. Scolastico C. Eur. J. Org. Chem.  1999,  389 

55 Halab L. Lubell WD. J. Org. Chem.  1999,  64:  3312 

56 Halab L. Lubell WD. J. Am. Chem. Soc.  2002,  124:  2474 

57 Dumas J.-P. Germanas JP. Tetrahedron Lett.  1994,  35:  1495 

58 Kim K. Germanas JP. J. Org. Chem.  1997,  62:  2847 

59 Cumberbatch S. North M. Zagotto G. Tetrahedron  1993,  49:  9049 

60 An SSA. Lester CC. Peng J.-L. Li Y.-J. Rothwarf DM. Welker E. Thannhauser TW. Zhang LS. Tam JP. Scheraga HA. J. Am. Chem. Soc.  1999,  121:  11558 

61 Keller M. Sager C. Dumy P. Schutkowsky M. Fischer GS. Mutter M. J. Am. Chem. Soc.  1998,  120:  2714 

62 Brady SF. Paleveda WJ. Arison BH. Saperstein R. Brady EJ. Raynor K. Reisine T. Veber DF. Freidinger RM. Tetrahedron  1993,  49:  3449 

63 Sukumaran DK. Prorok M. Lawrence DS. J. Am. Chem. Soc.  1991,  113:  706 

64 Zabrocki J. Smith GD. Dunbar JB. Marshall GR. J. Am. Chem. Soc.  1988,  110:  5875 

65 Souers AJ. Virgilio AA. Schürer SS. Ellman JA. Kogan TP. West HE. Ankener W. Vanderslice P. Bioorg. Med. Chem. Lett.  1998,  8:  2297 

66 Cho N. Harada M. Imaeda T. Imada T. Matsumoto H. Hayase Y. Sasaki S. Furuya S. Suzuki N. Okubo S. Ogi S. Endo S. Onda H. Fujino M. J. Med. Chem.  1998,  41:  4190 

67 Souers AJ. Virgilio AA. Rosenquist Ĺ. Fenuik W. Ellman JA. J. Am. Chem. Soc.  1999,  121:  1817 

68 Virgilio AA. Ellman JA. J. Am. Chem. Soc.  1994,  116:  11580 

69 Virgilio AA. Schürer SC. Ellman JA. Tetrahedron Lett.  1996,  37:  6961 

70 Virgilio AA. Bray AA. Zhang W. Trinh L. Snyder M. Morissey M. Ellman JA. Tetrahedron  1997,  53:  6635 

71 Feng Y. Wang Z. Jin S. Burgess K. J. Am. Chem. Soc.  1998,  120:  10768 

72 Eguchi M. Lee MS. Nakanishi H. Stasiak M. Lovell S. Kahn M. J. Am. Chem. Soc.  1999,  121:  12204 

73 Nagai U. Sato K. Tetrahedron Lett.  1985,  26:  647 

74 Feigel M. J. Am. Chem. Soc.  1986,  108:  181 

75 Diaz H. Espina JR. Kelly JW. J. Am. Chem. Soc.  1992,  114:  8316 

76 Genin MJ. Johnson RL. J. Am. Chem. Soc.  1992,  114:  8778 

77 Jones IG. Jones W. North M. J. Org. Chem.  1998,  63:  1505 

78 Holmes DL. Smith EM. Nowick JS. J. Am. Chem. Soc.  1997,  119:  7655 

79 Smith EM. Holmes DL. Shaka AJ. Nowick JS. J. Org. Chem.  1997,  62:  7906 

80 Nesloney CL. Kelly JW. J. Am. Chem. Soc.  1996,  118:  5836 

81 Gardner RR. Liang G.-B. Gellman SH. J. Am. Chem. Soc.  1995,  117:  3280 

82 Schneider JP. Kelly JW. J. Am. Chem. Soc.  1995,  117:  2533 

83 Kemp DS. Li ZQ. Tetrahedron Lett.  1995,  36:  4179 

84 Gardner B. Nanashi H. Khan M. Tetrahedron  1993,  49:  3433 

85 Brandmeier V. Feigel M. Angew. Chem., Int. Ed. Engl.  1989,  28:  486 ; Angew. Chem. 1989, 102, 466

86 Nowick S. Smith EM. Noronha G. J. Org. Chem.  1995,  60:  7386 

87 Nagai U. Sato K. Nakamura R. Kato R. Tetrahedron  1993,  49:  3577 

88 Kemp DS. Sites WE. Tetrahedron Lett.  1988,  29:  5057 

89 Haque TS. Gellman SH. J. Am. Chem. Soc.  1997,  119:  2303 

90 Krauthäuser S. Christianson LA. Powell DR. Gellman SH. J. Am. Chem. Soc.  1997,  119:  11719 

91 Hanessian S. Yang H. Tetrahedron Lett.  1997,  38:  3155 

92 Fink BE. Kym PR. Katzenellenbogen JA. J. Am. Chem. Soc.  1998,  120:  4334 

93 Hanessian S. McNaughton-Smith G. Lombart H.-G. Lubell WD. Tetrahedron  1997,  53:  12789 

94 Wishart DS. Sykes BD. Richards FM. J. Mol. Biol.  1991,  222:  311 

95 Chang G. Guida WC. Still WC. J. Comput. Chem.  1994,  15:  1302 

96 Ball JB. Hughes RA. Alewood PF. Andrews PR. Tetrahedron  1993,  49:  3467 

97 Scarpi D. Occhiato EG. Trabocchi A. Leatherbarrow RJ. Brauer ABE. Nievo M. Guarna A. Bioorg. Med. Chem.  2001,  9:  1625 

98 Trabocchi A. Occhiato EG. Potenza D. Guarna A. J. Org. Chem.  2002,  67:  7483 

99 Trabocchi A. Potenza D. Guarna A. Eur. J. Org. Chem.  2004,  4621 

100 Fisk JD. Powell DR. Gellman SH. J. Am. Chem. Soc.  2000,  122:  5443